Interactive Review May Be Revamped In 2012 User Fee Agreement
This article was originally published in The Gray Sheet
Executive Summary
Acknowledging the shortcomings of the program, FDA is considering improving the interactive review process as part of its negotiations with industry on reauthorizing the medical device user fee program.